OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $841,000 | -67.4% | 1,956,345 | -57.3% | 0.00% | -100.0% |
| Q1 2016 | $2,578,000 | -66.3% | 4,581,728 | +3.0% | 0.00% | -50.0% |
| Q4 2015 | $7,650,000 | -18.6% | 4,447,403 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $9,403,000 | -56.2% | 4,456,432 | +2.8% | 0.00% | -60.0% |
| Q2 2015 | $21,462,000 | -45.0% | 4,335,679 | -13.0% | 0.01% | -44.4% |
| Q1 2015 | $39,040,000 | +32.4% | 4,985,939 | +2.4% | 0.01% | +28.6% |
| Q4 2014 | $29,494,000 | +55.8% | 4,867,002 | +9.5% | 0.01% | +40.0% |
| Q3 2014 | $18,927,000 | -27.8% | 4,442,897 | +4.8% | 0.01% | -28.6% |
| Q2 2014 | $26,207,000 | -6.7% | 4,240,589 | -1.9% | 0.01% | -12.5% |
| Q1 2014 | $28,098,000 | +27.7% | 4,322,696 | +10.6% | 0.01% | +14.3% |
| Q4 2013 | $22,008,000 | -4.3% | 3,909,129 | +4.2% | 0.01% | -12.5% |
| Q3 2013 | $23,005,000 | +21.6% | 3,752,865 | +15.9% | 0.01% | +14.3% |
| Q2 2013 | $18,925,000 | – | 3,237,873 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |